Ascendiant Capital Markets Reiterates “Buy” Rating for Heart Test Laboratories (NASDAQ:HSCS)

Heart Test Laboratories (NASDAQ:HSCS)‘s stock had its “buy” rating restated by stock analysts at Ascendiant Capital Markets in a research note issued to investors on Monday, Benzinga reports. They currently have a $15.00 price objective on the stock. Ascendiant Capital Markets’ price target suggests a potential upside of 252.94% from the stock’s previous close.

Heart Test Laboratories Price Performance

NASDAQ:HSCS opened at $4.25 on Monday. Heart Test Laboratories has a 1 year low of $2.36 and a 1 year high of $52.00. The stock’s fifty day moving average price is $3.39 and its two-hundred day moving average price is $6.44. The company has a market cap of $2.79 million, a P/E ratio of -0.09 and a beta of 3.13.

Heart Test Laboratories Company Profile

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.